November 8, 2017 / 12:03 PM / in a month

BRIEF-Merrimack reports Q3 loss per share from continuing operations $0.40

Nov 8 (Reuters) - Merrimack Pharmaceuticals Inc

* Merrimack reports third quarter 2017 financial results

* Merrimack Pharmaceuticals Inc - Qtrly loss per share from continuing operations $0.40

* Merrimack Pharmaceuticals-Believes unrestricted cash & cash equivalents & payments from shire will be sufficient to fund operations into H2 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below